This inventor holds 4 USPTO granted patents. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kogyo Kabushiki. Active years: 1985-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shizuoka, JP (1986)
- Susono, JP (1985 - 1987)
Company Filing History:
Years Active: 1985-1987
Title: Yuko Arai: Innovator in Microbial Fermentation
Introduction
Yuko Arai is a prominent inventor based in Susono, Japan. She has made significant contributions to the field of microbial fermentation, particularly in the production of mitomycin A. With a total of 4 patents to her name, Arai's work has had a notable impact on anti-tumor therapies.
Latest Patents
One of her latest patents is titled "Process and microorganisms for producing mitomycin A by fermentation." This innovative process involves culturing a microorganism from the genus Streptomyces, which is capable of producing mitomycin A while exhibiting specific properties. The microorganism used in this process is preferably Streptomyces caespitosus T-17-135 (NRRL 12508) or Streptomyces caespitosus (NRRL 12513). Another significant patent is for "DX-52-1 compounds and process for preparing the same." This patent describes a compound with a specific formula and outlines a process for its preparation, which is aimed at creating an anti-tumor composition that is more stable than the starting compound DC-52.
Career Highlights
Yuko Arai has worked with notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kogyo Kabushiki. Her experience in these organizations has allowed her to develop her expertise in microbial fermentation and contribute to advancements in the field.
Collaborations
Throughout her career, Arai has collaborated with esteemed colleagues, including Shigeo Katsumata and Shinzo Ishii. These collaborations have further enriched her research and innovation efforts.
Conclusion
Yuko Arai's contributions to microbial fermentation and her innovative patents have positioned her as a key figure in the field. Her work continues to influence the development of effective anti-tumor therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
